Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-funding notice and the government operating status update, and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:41:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a site-wide notice about the lapse in government funding and open status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:31:16.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Show glossary has been added, and several metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Related topics and legacy labels (e.g., Melanoma, MedlinePlus Genetics, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.4%
    Check dated 2026-01-28T03:54:04.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and a MedlinePlus Genetics link as related topics on the study page.
    Difference
    0.2%
    Check dated 2026-01-21T04:45:06.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added; Melanoma, related topics: MedlinePlus Genetics, and Revision: v3.3.3 were removed from the page.
    Difference
    0.2%
    Check dated 2026-01-14T03:17:10.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Melanoma is added as the condition category and MedlinePlus Genetics is added as a related topic.
    Difference
    0.2%
    Check dated 2026-01-07T01:37:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.